Found 69 bookmarks
Newest
A shark-derived broadly neutralizing nanobody targeting a highly conserved epitope on the S2 domain of sarbecoviruses - Journal of Nanobiotechnology
A shark-derived broadly neutralizing nanobody targeting a highly conserved epitope on the S2 domain of sarbecoviruses - Journal of Nanobiotechnology
“The continuously evolving Omicron subvariants has diminished the effectiveness of almost all RBD-targeted antibodies in neutralizing these subvariants. The development of broad-spectrum neutralizing antibodies is desired for addressing both current and future variants. Here, we identified a shark-derived nanobody, 79C11, that can neutralize all Omicron subvariants tested so far, including BA.1 to JN.1 and KP.2, and exhibits comparable neutralizing potency against SARS-CoV-1 and pangolin coronavirus. Intranasal instillation of 79C11 can effectively prevent the infection of Omicron subvariant XBB in vivo.”
·jnanobiotechnology.biomedcentral.com·
A shark-derived broadly neutralizing nanobody targeting a highly conserved epitope on the S2 domain of sarbecoviruses - Journal of Nanobiotechnology
Mitigating the risks of post-acute sequelae of SARS-CoV-2 infection (PASC) with intranasal chlorpheniramine: perspectives from the ACCROS studies
Mitigating the risks of post-acute sequelae of SARS-CoV-2 infection (PASC) with intranasal chlorpheniramine: perspectives from the ACCROS studies
This interesting study shows that use of intranasal antihistamine chlorpheniramine may prevent COVID-19 progression to Long COVID when used during acute infection.
·pmc.ncbi.nlm.nih.gov·
Mitigating the risks of post-acute sequelae of SARS-CoV-2 infection (PASC) with intranasal chlorpheniramine: perspectives from the ACCROS studies
Quick 🧵on the current state of Iota-carrageenan nasal sprays: Efficacy, safety, Betadine shortages, buying options for US & Can. markets.
Quick 🧵on the current state of Iota-carrageenan nasal sprays: Efficacy, safety, Betadine shortages, buying options for US & Can. markets.

“Quick 🧵on the current state of Iota-carrageenan nasal sprays: Efficacy, safety, Betadine shortages, buying options for US & Can. markets.

I-C sprays are the only option on the market that have a real-world randomized, double-blind, placebo-controlled study backing them up. 1/14”

·x.com·
Quick 🧵on the current state of Iota-carrageenan nasal sprays: Efficacy, safety, Betadine shortages, buying options for US & Can. markets.
A Drug-Free Nasal Spray May Shield Against Respiratory Infections
A Drug-Free Nasal Spray May Shield Against Respiratory Infections

“Current nasal sprays offer limited protection against respiratory pathogens because they have a single mechanism of protection. They either neutralize pathogens or block their entry into the cells lining the nose, and they perform both tasks with limited efficacy.

‘We developed a drug-free formulation to block germs in three ways — the spray forms a gel-like matrix that enhances the capture of respiratory droplets, immobilizes the germs blocking their transport into the nasal lining, and effectively neutralizes them, preventing infection,’”

·hms.harvard.edu·
A Drug-Free Nasal Spray May Shield Against Respiratory Infections
A NEW nasal spray that trap & neutralize not only SARS-CoV-2, Influenza, RSV, Adeno & many other viruses & bacteria that are inhaled into the nose, immobilizing them until they die. The substance is 99.9% effective & contains no drugs 1/
A NEW nasal spray that trap & neutralize not only SARS-CoV-2, Influenza, RSV, Adeno & many other viruses & bacteria that are inhaled into the nose, immobilizing them until they die. The substance is 99.9% effective & contains no drugs 1/
“NEW nasal spray that trap & neutralize not only SARS-CoV-2, Influenza, RSV, Adeno & many other viruses & bacteria that are inhaled into the nose, immobilizing them until they die. The substance is >99.9% effective & contains no drugs 1/“
·x.com·
A NEW nasal spray that trap & neutralize not only SARS-CoV-2, Influenza, RSV, Adeno & many other viruses & bacteria that are inhaled into the nose, immobilizing them until they die. The substance is 99.9% effective & contains no drugs 1/
Preclinical studies suggest a drug-free nasal spray could ward off respiratory infections
Preclinical studies suggest a drug-free nasal spray could ward off respiratory infections

“Preclinical studies suggest a drug-free nasal spray could ward off respiratory infections Researchers from the Brigham detail how the spray they created may offer broad-spectrum protection from respiratory infections by COVID-19, influenza, everyday cold viruses, and pneumonia-causing bacteria”

·eurekalert.org·
Preclinical studies suggest a drug-free nasal spray could ward off respiratory infections
🔥 New, promising data on Profi Nasal Spray (aka PCANS) as prophylaxis for respiratory viruses:
🔥 New, promising data on Profi Nasal Spray (aka PCANS) as prophylaxis for respiratory viruses:

New, promising data on Profi Nasal Spray (aka PCANS) as prophylaxis for respiratory viruses:

“The researchers developed the formulation and studied its ability to capture respiratory droplets in a 3D-printed replica of a human nose. They showed that when sprayed in the nasal cavity replica, PCANS captured twice as many droplets as mucus alone.

·x.com·
🔥 New, promising data on Profi Nasal Spray (aka PCANS) as prophylaxis for respiratory viruses:
Washing Illness Away: A Systematic Review of the Impact of Nasal Irrigation and Spray on COVID‐19 - Gandhi - The Laryngoscope - Wiley Online Library
Washing Illness Away: A Systematic Review of the Impact of Nasal Irrigation and Spray on COVID‐19 - Gandhi - The Laryngoscope - Wiley Online Library
“Nasal irrigation is a common treatment for sinonasal disorders; however, it is unknown if it can reduce SARS-CoV-2 nasopharyngeal viral load (NVL). This systematic review investigated the efficacy of nasal irrigation with saline, povidone iodine (PVP-I), and intranasal corticosteroids (INCS) at reducing SARS-CoV-2 NVL and transmissibility.
·onlinelibrary.wiley.com·
Washing Illness Away: A Systematic Review of the Impact of Nasal Irrigation and Spray on COVID‐19 - Gandhi - The Laryngoscope - Wiley Online Library
Saline nasal irrigation and gargling in COVID-19: a multidisciplinary review of effects on viral load, mucosal dynamics, and patient outcomes
Saline nasal irrigation and gargling in COVID-19: a multidisciplinary review of effects on viral load, mucosal dynamics, and patient outcomes
“While it is acknowledged that a short 30-s contact of saline with the SARS-CoV-2 virus does not exhibit direct virucidal activity (131), this narrative review on SI revealed that nasal SI performed repeatedly for 1 day may lead to a significant reduction in nasopharyngeal virus load, while a repeated application for 7–10 days leads to faster viral clearance. Overall, patients with positive swab tests experienced substantial viral load reduction, became PCR-negative faster, and had milder symptoms than untreated patients.”
·ncbi.nlm.nih.gov·
Saline nasal irrigation and gargling in COVID-19: a multidisciplinary review of effects on viral load, mucosal dynamics, and patient outcomes
Astodrimer sodium nasal spray forms a barrier to SARS-CoV-2 in vitro and preserves normal mucociliary function in human nasal epithelium
Astodrimer sodium nasal spray forms a barrier to SARS-CoV-2 in vitro and preserves normal mucociliary function in human nasal epithelium
Study in Australia on 14 human donors: Astodrimer sodium nasal spray reduced SARS-CoV-2 infectivity by 96.6% and preserved normal mucociliary function.
·nature.com·
Astodrimer sodium nasal spray forms a barrier to SARS-CoV-2 in vitro and preserves normal mucociliary function in human nasal epithelium
A randomized, double-blind, placebo-controlled phase 1 trial of inhaled and intranasal niclosamide: A broad spectrum antiviral candidate for treatment of COVID-19
A randomized, double-blind, placebo-controlled phase 1 trial of inhaled and intranasal niclosamide: A broad spectrum antiviral candidate for treatment of COVID-19
"A randomized, double-blind, placebo-controlled phase 1 trial of inhaled and intranasal niclosamide: A broad spectrum antiviral candidate for treatment of COVID-19"
·thelancet.com·
A randomized, double-blind, placebo-controlled phase 1 trial of inhaled and intranasal niclosamide: A broad spectrum antiviral candidate for treatment of COVID-19
laurie allee on Twitter
laurie allee on Twitter

Starting thread on niclosamide:

"These researchers developed a prophylactic nasal spray and early treatment throat spray by repurposing niclosamide, a metabolic inhibitor previously used for 60 years for gut parasite infections." https://dukechronicle.com/article/2022/03/duke-university-scientist-coronavirus-covid-treatment-nasal-spray#:~:text=Niclosamide%20works%20by%20blocking%20three%20of%20the%20six,said.%20Formerly%2C%20niclosamide%20was%20FDA-approved%20in%20pill%20form.

·twitter.com·
laurie allee on Twitter
The pH Dependence of Niclosamide Solubility, Dissolution, and Morphology: Motivation for Potentially Universal Mucin-Penetrating Nasal and Throat Sprays for COVID19, its Variants and other Viral Infections - PubMed
The pH Dependence of Niclosamide Solubility, Dissolution, and Morphology: Motivation for Potentially Universal Mucin-Penetrating Nasal and Throat Sprays for COVID19, its Variants and other Viral Infections - PubMed
"prophylactic-nasal and early-treatment throat-sprays could help prevent infection and reduce viral load. Niclosamide has the potential to treat a broad-range of viral infections...as mucin-penetrating solutions that can reach underlying epithelial cells."
·pubmed.ncbi.nlm.nih.gov·
The pH Dependence of Niclosamide Solubility, Dissolution, and Morphology: Motivation for Potentially Universal Mucin-Penetrating Nasal and Throat Sprays for COVID19, its Variants and other Viral Infections - PubMed
Covixyl Nasal Spray
Covixyl Nasal Spray

Protection that Lasts up to 6 Hours Safe Covixyl® can be used daily as needed without reducing the effectiveness of the product. Because Covixyl® is not a drug, there are no side effects or adverse interactions.

·covixyl.com·
Covixyl Nasal Spray
The Anti-Histamine Azelastine, Identified by Computational Drug Repurposing, Inhibits Infection by Major Variants of SARS-CoV-2 in Cell Cultures and Reconstituted Human Nasal Tissue
The Anti-Histamine Azelastine, Identified by Computational Drug Repurposing, Inhibits Infection by Major Variants of SARS-CoV-2 in Cell Cultures and Reconstituted Human Nasal Tissue
The Anti-Histamine Azelastine, Identified by Computational Drug Repurposing, Inhibits Infection by Major Variants of SARS-CoV-2 in Cell Cultures and Reconstituted Human Nasal Tissue
·t.co·
The Anti-Histamine Azelastine, Identified by Computational Drug Repurposing, Inhibits Infection by Major Variants of SARS-CoV-2 in Cell Cultures and Reconstituted Human Nasal Tissue